BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38376304)

  • 21. [Radiotherapy for patients with early-stage glottic squamous cell carcinoma of the larynx: Interest of hypofractionation?].
    Tonneau M; Matta R; Lals S; Mirabel X; Crop F; Lacornerie T; Pasquier D; Escande A; Liem X
    Cancer Radiother; 2021 Dec; 25(8):801-810. PubMed ID: 33931299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimized treatment strategy of radiotherapy for early glottic squamous cell carcinomas: An initial analysis.
    Kimura K; Itoh Y; Okada T; Kubota S; Kawamura M; Nakahara R; Oie Y; Kozai Y; Takase Y; Tsuzuki H; Nishio N; Hiramatsu M; Fujimoto Y; Mizutani T; Naganawa S
    Nagoya J Med Sci; 2017 Aug; 79(3):331-338. PubMed ID: 28878438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase 1 Fractional Dose-Escalation Study of Equipotent Stereotactic Radiation Therapy Regimens for Early-Stage Glottic Larynx Cancer.
    Sher DJ; Timmerman RD; Nedzi L; Ding C; Pham NL; Zhao B; Sumer BD
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):110-118. PubMed ID: 30880269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of radiation therapy fraction size on local control of early glottic carcinoma.
    Yu E; Shenouda G; Beaudet MP; Black MJ
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):587-91. PubMed ID: 9112457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience.
    Murgic J; Jaksic B; Prpic M; Kust D; Bahl A; Budanec M; Prgomet Secan A; Franco P; Kruljac I; Spajic B; Babic N; Kruslin B; Zovak M; Zubizarreta E; Rosenblatt E; Fröbe A
    Radiat Oncol; 2021 May; 16(1):88. PubMed ID: 33980277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective analysis of therapeutic effect and prognostic factors on early glottic carcinoma.
    Peng Z; Li Y; Jin L; Tao X; Cai X; Feng J; Liu R; Zhang Q; Li L
    Photodiagnosis Photodyn Ther; 2016 Sep; 15():167-71. PubMed ID: 27378675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerated radiotherapy for T1, 2 glottic carcinoma: analysis of results with KI-67 index.
    Sakata K; Oouchi A; Nagakura H; Akiba H; Tamakawa M; Koito K; Hareyama M; Asakura K; Satoh M; Ohtani S
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):81-8. PubMed ID: 10758308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypofractionated radiotherapy for T1N0M0 glottic cancer: retrospective analysis of two different cohorts of dose-fractionation schedules from a single institution.
    Laskar SG; Baijal G; Murthy V; Chilukuri S; Budrukkar A; Gupta T; Agarwal JP
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e180-6. PubMed ID: 22862908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation.
    Spector JG; Sessions DG; Chao KS; Haughey BH; Hanson JM; Simpson JR; Perez CA
    Head Neck; 1999 Dec; 21(8):707-17. PubMed ID: 10562683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transoral laser microsurgery versus radiotherapy for T2 glottic squamous cell carcinoma: a systematic review of local control outcomes.
    Warner L; Lee K; Homer JJ
    Clin Otolaryngol; 2017 Jun; 42(3):629-636. PubMed ID: 27863075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accelerated radiotherapy for T1 to T2 glottic cancer.
    Motegi A; Kawashima M; Arahira S; Zenda S; Toshima M; Onozawa M; Hayashi R; Akimoto T
    Head Neck; 2015 Apr; 37(4):579-84. PubMed ID: 24677592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetric comparison of intensity-modulated radiation therapy for early-stage glottic cancers with and without the air cavity in the planning target volume.
    Asher D; Amestoy W; Studenski MT; Samuels SE; Abramowitz MC; Freedman LM; Elsayyad N; Samuels MA
    Med Dosim; 2019 Winter; 44(4):405-408. PubMed ID: 30928177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
    Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M
    Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of survival between radiation therapy and trans-oral laser microsurgery for early glottic cancer patients; a retrospective cohort study.
    De Santis RJ; Poon I; Lee J; Karam I; Enepekides DJ; Higgins KM
    J Otolaryngol Head Neck Surg; 2016 Aug; 45(1):42. PubMed ID: 27485726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of radiation therapy for T1 glottic carcinoma from an Italian regional series with doses ranging from 60 to 66 Gy.
    Manzo R; Ravo V; Murino P; Morra A; Panetti G; Laudati A; Prisco A; Panelli G; Muto P
    Tumori; 2010; 96(4):577-81. PubMed ID: 20968137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensity-modulated radiotherapy for early-stage glottic cancer.
    Berwouts D; Swimberghe M; Duprez F; Boterberg T; Bonte K; Deron P; De Gersem W; De Neve W; Madani I
    Head Neck; 2016 Apr; 38 Suppl 1():E179-84. PubMed ID: 25537856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiotherapy for laryngeal cancer-technical aspects and alternate fractionation.
    Yamazaki H; Suzuki G; Nakamura S; Yoshida K; Konishi K; Teshima T; Ogawa K
    J Radiat Res; 2017 Jul; 58(4):495-508. PubMed ID: 28898958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fractionation scheme and treatment planning method for early glottic cancer in the United States: Economic impact of different medical decisions.
    Moore A; Den RB; Popovtzer A; Goldvaser H; Gordon N; Goldstein DA
    Head Neck; 2020 Aug; 42(8):1713-1720. PubMed ID: 31976607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poor local control of ulcerative T1 glottic cancer treated with 2.25-Gy per fraction radiotherapy.
    Oie Y; Itoh Y; Kawamura M; Takase Y; Murao T; Ishihara S; Nomoto Y; Hirasawa N; Asano A; Yamakawa K; Ito J; Kinoshita F; Naganawa S
    Nagoya J Med Sci; 2021 Nov; 83(4):811-825. PubMed ID: 34916724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study design and early result of a phase I study of SABR for early-stage glottic cancer.
    Yu T; Wee CW; Choi N; Wu HG; Kang HC; Park JM; Kim JI; Kim JH; Kwon TK; Chung EJ
    Laryngoscope; 2018 Nov; 128(11):2560-2565. PubMed ID: 29756264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.